2014 annual financial data
Aldeyra Therapeutics 2014 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -7,271,000 USD and net income was -5,187,000 USD.
Operating cash flow was -4,775,994 USD.
Get free Aldeyra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,271,000 USD
- Net income
- -5,187,000 USD
- Operating cash flow
- -4,775,994 USD